Get the latest gossip
Diana Taurasi Urges Patience With Caitlin Clark and WNBA's Rookie Class
In an exclusive interview with Us, WNBA veteran Diana Taurasi said critics of Caitlin Clark, Angel Reese and the rest of the WNBA rookie class need to put down their pitchforks
Taurasi, 42 — who spoke to Us Weekly to discuss his partnership with eczema medication Dupixent — pushed back at some of the early criticism that has been thrown in the direction of this year’s WNBA rookie class, including Caitlin Clark, for an arguably underwhelming start to their respective seasons. Taurasi further contended that much of the venom being spewed in the direction of Clark, Angel Reese, Cameron Brink and other first-year players is from male journalists who are just starting to open their eyes to women’s basketball. After she began taking Dupixent as a treatment option, Taurasi partnered with Sanofi and Regeneron to raise awareness about the everyday challenges of dealing with the skin condition — and how getting it under control has made her feel even more confident on the court.
Or read this on Us Weekly
